Merck & Co., Inc.
MRK
$87.37
$1.291.50%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 19.44% | 656.03% | 4,589.59% | 163.63% | 341.53% |
| Total Depreciation and Amortization | 13.35% | 19.10% | 13.75% | 9.09% | 5.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 157.54% | -73.34% | -66.05% | -67.62% | -91.01% |
| Change in Net Operating Assets | -152.97% | -48.20% | -66.30% | 38.13% | 55.03% |
| Cash from Operations | 11.05% | 41.48% | 65.06% | 6.25% | 10.71% |
| Capital Expenditure | -7.59% | -3.28% | 12.71% | 14.89% | 16.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -348.66% | 70.77% | 65.98% | 66.00% | 93.86% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -124.76% | -131.87% | -114.85% | 647.37% | 1,495.54% |
| Cash from Investing | -176.82% | 40.11% | 45.08% | 60.73% | 83.49% |
| Total Debt Issued | -97.16% | -39.40% | -39.40% | -39.40% | -78.99% |
| Total Debt Repaid | -302.52% | -21.32% | 26.50% | 56.99% | 72.57% |
| Issuance of Common Stock | -72.25% | -40.11% | 41.60% | -55.47% | -55.30% |
| Repurchase of Common Stock | -179.38% | -78.01% | 2.97% | -26.97% | -152.98% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.08% | -5.28% | -5.31% | -5.42% | -5.64% |
| Other Financing Activities | -5.47% | -8.92% | -13.41% | 15.27% | 10.63% |
| Cash from Financing | -81.77% | -79.05% | -46.20% | -52.17% | -217.87% |
| Foreign Exchange rate Adjustments | 339.27% | 100.50% | -1,373.91% | 28.08% | -267.31% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -158.29% | 174.39% | 209.29% | 330.61% | 240.09% |